tamibarotene has been researched along with imatinib mesylate in 1 studies
| Studies (tamibarotene) | Trials (tamibarotene) | Recent Studies (post-2010) (tamibarotene) | Studies (imatinib mesylate) | Trials (imatinib mesylate) | Recent Studies (post-2010) (imatinib mesylate) |
|---|---|---|---|---|---|
| 198 | 10 | 105 | 11,477 | 960 | 5,773 |
| Protein | Taxonomy | tamibarotene (IC50) | imatinib mesylate (IC50) |
|---|---|---|---|
| Tyrosine-protein kinase ABL1 | Homo sapiens (human) | 0.31 | |
| Mast/stem cell growth factor receptor Kit | Homo sapiens (human) | 0.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mitani, K | 1 |
1 review(s) available for tamibarotene and imatinib mesylate
| Article | Year |
|---|---|
[Molecular physiopathology and molecular targeting therapy of leukemia].
Topics: Benzamides; Benzoates; Humans; Imatinib Mesylate; Leukemia; Piperazines; Pyrimidines; Tetrahydronaphthalenes | 2007 |